ArticleThe Indian journal of medical research2025
The untold story of elimination of human schistosomiasis from Gimavi village, Ratnagiri district, Maharashtra State, India: A qualitative study.
Article in The Indian journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Authors' response.The Indian journal of medical research · 2025Review
- From local triumph to global learning: Gimavi village & the journey toward schistosomiasis elimination.The Indian journal of medical research · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background & objectives Infection with Schistosoma haematobium (S. haematobium) is associated with substantial morbidity and mortality in humans, primarily affecting the African countries. In 1952, a pathology professor discovered an endemic focus of S. haematobium in a small village named Gimavi in Ratnagiri district, Maharashtra. Its emergence about 5,000 km away from its homeland in Africa, the absence of the known vector, Bullinus, in India, and its confinement to only one village were enigmatic. The Government of Maharashtra executed several activities and eliminated the focus after about 40 years. Many practicing and teaching public health experts today are unaware of the focus and the efforts undertaken for its elimination. This study's objectives were to identify clinical features, enlist the containment activities undertaken by the government, and identify reasons for confinement. Methods We conducted a qualitative study using in-depth interviews. All available past patients, two health personnel (male and female health workers), a medical officer, a district health officer, the concerned senior officer from the Directorate of Health Services, a scientist from Haffkine Institute, Gramsevak/Talathi (village level healthcare workers), Sarpanch/Up-sarpanch (administrative heads of a large village or a cluster of small villages), at least one from each category, were interviewed. The study included persons who worked during that period. Results The investigator interviewed ten personnel and two past patients. Many children had painless and mild haematuria, which persisted for some years. All respondents knew about the tiny snails living in the rivulet transmitted the disease. Construction of bridges, tanks, toilets, water supply schemes, barbed fencing along banks, manual collection/destruction of snails, health education, and mass drug administration eliminated the focus. Besides Gimavi, the rivulet flows through two villages and joins an estuary of a river where, due to high salinity, tiny freshwater snails cannot survive. Interpretation & conclusions A new species of snail was discovered to transmit S. haematobium. The disease was mild and self-limiting. A multipronged attack eliminated the focus. The unique environmental conditions restricted the spread of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.